Angiodroid uses through a dedicated automatic injector, CO2 (a natural gas, biocompatible for humans) to drastically reduce Contrast Induced Nephropathy, a leading cause for kidney failure in patients during hospitalisation, preserving the renal function of thousands of patients, every year.

2021 SIT finalist

Sectors: Health

Country: Italy

Country(s) of implementation: Germany, France, Italy, United Kingdom, Spain